Guided Therapeutics (GTHP) Change in Accured Expenses (2011 - 2025)

Guided Therapeutics has disclosed Change in Accured Expenses across 15 years of filings, most recently posting $832000.0 for Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at $832000.0, up 433.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.4 million (up 150.09% YoY), and the FY2025 annual result was $1.4 million, up 150.09% from the prior year.
• Change in Accured Expenses came in at $832000.0 for Q4 2025 at Guided Therapeutics, up from $204000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $832000.0 in Q4 2025 to a low of -$450000.0 in Q3 2021.
• The 5-year median for Change in Accured Expenses is $75000.0 (2022), against an average of $110450.0.
• Across the five-year window, Change in Accured Expenses slumped 454.33% in 2021 and soared 2009.52% in 2024, its largest moves.
• Guided Therapeutics' Change in Accured Expenses stood at $571000.0 in 2021, then plunged by 77.41% to $129000.0 in 2022, then soared by 34.11% to $173000.0 in 2023, then decreased by 9.83% to $156000.0 in 2024, then jumped by 433.33% to $832000.0 in 2025.
• The last three Change in Accured Expenses figures came in at $832000.0 (Q4 2025), $204000.0 (Q3 2025), and $221000.0 (Q2 2025), per Business Quant data.